Pemphigoid
Not recruitingStudy on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid
- Disease:Pemphigoid
- Substances:Efgartigimod AlfaPrednisone
Greece- Participants:18–64 years · 65+ years
- Substances:Efgartigimod Alfa
- Sponsor:Argenx
Rare diseases
Investigational molecules
Locations
Back to Greece114 clinical trials in Efkarpia, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
GreeceThe busiest research cities in the country
What the registry says about research in the country
Extensive trials focusing on hidradenitis suppurativa and atopic dermatitis, evaluating novel therapeutic approaches and treatment combinations to improve patient outcomes.
Multiple studies testing new biological therapies and their long-term safety profiles.
Research centered on lupus erythematosus and Sjögren's Disease, investigating targeted therapies to manage disease progression and symptoms.
Studies aim to evaluate new therapeutic agents for better disease control.
Innovative trials examining treatments for Type 2 Diabetes and obesity, with focus on cardiovascular outcomes and weight management.
Research comparing new therapeutic options against established treatments.
Advanced research in metastatic breast cancer and colorectal cancer, evaluating targeted therapies and combination treatments.
Focus on improving progression-free survival in advanced disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.